| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/14/2003 | CA2475493A1 Inclusion complexes of semicarbazones into cyclodetrins and uses thereof |
| 08/14/2003 | CA2474920A1 Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications |
| 08/14/2003 | CA2474398A1 New immunoeffector compounds |
| 08/14/2003 | CA2474142A1 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 08/14/2003 | CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins |
| 08/13/2003 | EP1334091A2 Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease |
| 08/13/2003 | EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 08/13/2003 | EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/13/2003 | EP0840570B1 Apparatus and method for making gas-filled vesicles of optimal size |
| 08/13/2003 | EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide |
| 08/13/2003 | EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 08/13/2003 | EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals |
| 08/13/2003 | EP0531472B1 Humanized monoclonal antibodies |
| 08/13/2003 | CN1436235A Anti-angiogenic polypeptides |
| 08/13/2003 | CN1435261A Thermosetting medical carrier composition with mucosa adsorption |
| 08/13/2003 | CN1117942C Resilent containers for hyperpolarized gases |
| 08/12/2003 | US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet |
| 08/12/2003 | US6605588 Amino acid sequence of SEQ ID NO:6 |
| 08/07/2003 | WO2003064646A1 Novel peptide and use thereof |
| 08/07/2003 | WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE |
| 08/07/2003 | WO2003064426A1 N, n'-dimethylated n-confused porphyrins |
| 08/07/2003 | WO2003063912A1 Responsive paramagnetic mri contrast agents |
| 08/07/2003 | WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 08/07/2003 | WO2003063759A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
| 08/07/2003 | WO2003032728A8 Methods for preventing or reversing asthma and compositions useful therefor |
| 08/07/2003 | WO2002056919A3 Visual marker for determining compliance with a medication regimen |
| 08/07/2003 | WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 08/07/2003 | US20030150005 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
| 08/07/2003 | US20030150004 Transgenic mice expressing human CAR receptor (retinoic acid receptors), wherein activity is increased via administration of 1,4-bis(2-(3,5-dichloropyridyloxy))benzene; cytochromes |
| 08/07/2003 | US20030150000 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom |
| 08/07/2003 | US20030149421 Method and apparatus for influencing the transport of blood carotenoids into intraductal breast fluid |
| 08/07/2003 | US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 08/07/2003 | US20030148926 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 08/07/2003 | US20030148533 Detecting production of 13C-labeled Krebs cycle metabolite precursor (glucose) via nuclear magnetic resonance spectroscopy upon exposure to deuteriated water |
| 08/07/2003 | US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors |
| 08/07/2003 | US20030148296 Drug screenig; administering compound and testing tissue for uncoupling protein 1, cytosolic malic enzyme and atrial natriuretic factor |
| 08/07/2003 | US20030147966 Nanoparticle delivery vehicle |
| 08/07/2003 | US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids |
| 08/07/2003 | US20030147881 Directed against a target antigen, cell culture to express, code the protein, for treating cancer |
| 08/07/2003 | US20030147811 Detection of Alzheimer's amyloid by magnetic resonance imaging |
| 08/07/2003 | US20030147780 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 08/07/2003 | CA2474593A1 N, n'-dimethylated n-confused porphyrins |
| 08/07/2003 | CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase |
| 08/06/2003 | EP1333274A2 Up-converting reporters for biological and other assays using laser excitation techniques |
| 08/06/2003 | EP1332764A1 A mucoadhesive thermoresponsive medicament-carrier composition |
| 08/06/2003 | EP1332364A2 In vivo detection of biomolecule concentrations using fluorescent tags |
| 08/06/2003 | EP1331951A2 Orally ingestible baked radiopaque product for testing for dysphagia |
| 08/05/2003 | US6602981 Antinociceptive agent derivative |
| 08/05/2003 | US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers |
| 08/05/2003 | US6602892 Methods for nicotine replacement dosage determination |
| 08/05/2003 | US6602715 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 08/05/2003 | US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals |
| 08/05/2003 | US6602488 Labeling of diseased or malfunctioning candidate cells for subsequent treatment; in situ gene therapy |
| 08/05/2003 | CA2089148C Oxidized complex comprising water-soluble carboxypolysaccaride and magnetic iron oxide |
| 08/05/2003 | CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies |
| 07/31/2003 | WO2003062198A1 Integrin targeted imaging agents |
| 07/31/2003 | WO2003061712A1 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
| 07/31/2003 | WO2003061711A2 Chromophore probes for optical imaging |
| 07/31/2003 | WO2003061621A2 Dermal application system for aminolevulinic acid-derivatives |
| 07/31/2003 | WO2003061593A2 Novel targeted compositions for diagnostic and therapeutic use |
| 07/31/2003 | WO2003020701A3 Multi-use multimodal imaging chelates |
| 07/31/2003 | WO2003001863A3 Novel endothelially expressed dnas and proteins, and their use |
| 07/31/2003 | WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 07/31/2003 | WO2002060941A3 Fluorescent proteins |
| 07/31/2003 | US20030144266 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/31/2003 | US20030144239 Expression system |
| 07/31/2003 | US20030144232 Expression system |
| 07/31/2003 | US20030144207 Hydrophilic conjugate having a peptide that is capable of passing the blood-brain barrier covalently linked to a water-soluble nonpeptidic polymer |
| 07/31/2003 | US20030143243 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/31/2003 | US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis |
| 07/31/2003 | US20030143159 Hydrophilic cyanine dyes |
| 07/31/2003 | US20030143158 For diagnosis and therapy of pathological intravascular thrombosis; for detecting, imaging, and localizing thrombi |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2473748A1 Novel targeted compositions for diagnostic and therapeutic use |
| 07/30/2003 | EP1331479A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like |
| 07/30/2003 | EP1331013A2 Improvements in or relating to contrast agents |
| 07/30/2003 | EP1331012A1 Responsive paramagnetic MRI contrast agents |
| 07/30/2003 | EP1330646A1 Methods for detecting vasculopathies and tumors |
| 07/30/2003 | EP1330645A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 07/30/2003 | EP1330639A1 Material which is provided with an nmr contrast agent and method for producing the same |
| 07/30/2003 | EP1330268A1 Targeted therapeutic agents |
| 07/30/2003 | EP1330267A1 Olfactory neuron cultures and method of making and using the same |
| 07/30/2003 | EP1330251A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 07/30/2003 | EP1330243A2 Use of carp inhibitors for the treatment of heart diseases |
| 07/30/2003 | EP1053026B1 Contrast medium based on polyoxethylene-660-12-hydroxystearate and anionic phospholipids |
| 07/30/2003 | EP0991428B1 Delta1,2 bicyclo 4,4,0] functional dyes for contrast enhancement in optical imaging |
| 07/30/2003 | EP0942780B1 Coated particles, methods of making and using |
| 07/30/2003 | CN1433326A Method for determining viability of myocardial segment |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6599497 Hyperpolarized helium-3 microbubble gas entrapment methods and associated products |
| 07/29/2003 | US6599496 Endoscopic tissue staining composition comprising a carbon pigment and a suspending/viscosity-increasing agent in a delivery vehicle, wherein carbon pigment has a level of total polycyclic aromatic hydrocarbon of less than 0.5 ppm |
| 07/29/2003 | US6599448 Radio-opaque polymeric compositions |
| 07/24/2003 | WO2003060525A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 07/24/2003 | WO2003060518A1 Diagnostic for schizophrenia |
| 07/24/2003 | WO2003060463A2 Methods of screening, determining, developing, and utilizing negative cross resistance toxins |
| 07/24/2003 | WO2003059325A1 Magnetic delivery compositions |
| 07/24/2003 | WO2003059251A2 Antibody targeting compounds |
| 07/24/2003 | WO2003059149A2 Methods for cancer imaging |